openPR Logo
Press release

Investigation announced for Investors in shares of Sage Therapeutics, Inc. (NASDAQ: SAGE)

08-25-2020 11:00 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Sage Therapeutics, Inc. (NASDAQ: SAGE) shares over potential securities laws violations.

An investigation for investors in Sage Therapeutics, Inc. (NASDAQ: SAGE) shares over potential securities laws violations.

An investigation on behalf of investors of Sage Therapeutics, Inc. (NASDAQ: SAGE) shares over potential securities laws violations by Sage Therapeutics, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

Investors who purchased shares of Sage Therapeutics, Inc. (NASDAQ: SAGE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Sage Therapeutics, Inc. (NASDAQ: SAGE) concerning whether a series of statements by Sage Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Cambridge, MA based Sage Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel medicines to treat central nervous system (CNS) disorders. Sage Therapeutics, Inc. reported that its annual Total Revenue declined from $90.27 million in 2018 to $6.86 million in 2019, and that its Net Loss increased from $372.88 million in 2018 to $680.23 million in 2019.

Shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) declined from $193.56 per share in July 2019 to as low as $25.01 per share on March 18, 2020.

Those who purchased shares of Sage Therapeutics, Inc. (NASDAQ: SAGE), have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) here

News-ID: 2121259 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) over potential Wrongdoing
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. directors breached their fiduciary duties and caused damage to the company and its
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company (NYSE: CC)
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company …
A deadline is coming up on May 20, 2024 in the lawsuit filed for certain investors of The Chemours Company (NYSE: CC) over alleged securities laws violations by The Chemours Company. Investors who purchased shares of The Chemours Company (NYSE: CC) have certain options and there are strict and short deadlines running. Deadline: May 20, 2024. NYSE: CC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for certain Investors who lost money with shares of Global Cord Blood Corporation (OTC: CORBF)
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ: ADSK)
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Sage

A Sage and Wise Choice Between Sage 50 (Simply Accounting) And Quickbooks
Brandon, MB––November 27, 2021: Sage 50 previously known as Peachtree or Simply Accounting traces its roots back to 1976 as part of The Computer SystemCenter – a microcomputer dealer. Peachtree was included in the initial launch of the first IBM PCs in 1981. By 1984, Peachtree was the seventh largest microcomputer software company generating nearly $22 million in revenue. Sage Group acquired Peachtree in the late 1990s and changed the product
The future of Sage SalesLogix unveiled at DMC Software with Sage workshops
Sage Saleslogix Business Partner of the Year, DMC Software Solutions, are hosting Sage SalesLogix Workshops which identify how SalesLogix CRM can support organisational growth and provide previews of the forthcoming SalesLogix developments. The DMC Software SalesLogix Sage Events are scheduled for 28th and 29th June 2011 in Peterborough and London, respectively. CRM experts from Sage and DMC Software explore the business potential Saleslogix can help to achieve, with a look to
Sage VARs See Continued Marketing Successes with Sage Product Newsletters
Sage ERP, CRM, HR, and Nonprofit product newsletters continue to be one of the best ways to stay in front of customers and keep them engaged with targeted content. Laguna Hills, CA, March 09, 2011 -- Juice Marketing has revealed that their Sage ERP, CRM, HR, and nonprofit product newsletters continue to be a popular marketing tool among Sage VARs despite the growing popularity of social media like Twitter, Facebook, and
Sage India Offers Better Insight into Your Business with Sage Accpac Insight 5.4
New Delhi –2009, Sage Software announced today the availability of Sage Accpac Insight 5.4, a new version of the company’s analysis and business intelligence tool for small and mid-sized businesses. Designed for use and integrated with Sage Accpac ERP1 (enterprise resource planning), Sage Accpac Insight utilizes key business data contained within Sage Accpac ERP, and is ideal for employees in remote offices and disparate departments who need to manage, distribute,
Agarwal Fasteners Tightens Operations with Sage Accpac ERP by Sage India
Agarwal Fasteners Tightens Operations with Sage Accpac ERP by Sage India • Real time view of inventory for informed procurement • Seamless integration of modules for zero duplication and errors • Automatic reports generated at the touch of a button • High data security for greater control New Delhi : Sage India, today announced that Agarwal Fasteners Pvt. Ltd., the specialized manufacturer of critical stainless steel fasteners as per industry standards
Bollhoff Fastenings India deploys Sage Accpac ERP implemented by Sage India
The real time view of stock availability and customer credit history has resulted in reducing errors and reorders during the sales process. Reports are generated automatically in the required format using predefined formulas. Consolidated view of company finances enables better budgetary estimations. Sage Software India (P) Ltd. today announced that Bollhoff Fastenings India, a wholly owned subsidiary of Bollhoff Germany, has successfully deployed Sage Accpac ERP. Sage Accpac is a highly scalable